1 result for month: 07/2018


FIRST CLINICAL RESEARCH SUPPORTED BY RAKFOND/RUSSCO GRANT STARTS AT N. N. BLOKHIN NATIONAL MEDICAL RESEARCH CENTRE OF ONCOLOGY

Alexey Rumyantsev is the principal researcher and winner of the RUSSCO/RakFond award The preparation was finished and first patients have been recruited for the clinical study of one of the winners of the first joint award of the Russian Society of Clinical Oncology (RUSSCO) and the Foundation for Cancer Research Support (RakFond). The aim of the study is to evaluate the efficacy and safety of a new regimen for the prevention of nausea and vomiting in chemotherapy. Up to 130 patients receiving chemotherapy with a high incidence of nausea and vomiting as side effects will be recruited for this open, randomized Phase II study. The new regimen of ...